Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Communications Medicine|March 20, 2024
IFNα induces CCR5 in CD4<sup>+</sup> T cells of HIV patients causing pathogenic elevationHélène Le Buanec, Valérie Schiavon, Marine Merandet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2025
Rapid increase in serotype 4 invasive pneumococcal disease among vulnerable young male adults in Belgium (2020-2024)Lize Cuypers, Gerardo J Sanchez, Juan Paulo Herrera Avila, et al.
EMBO Molecular Medicine|December 19, 2015
Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1Sophie Bouchat, Nadège Delacourt, Anna Kula, et al.
Open Forum Infectious Diseases|June 26, 2023
Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020Nadine Mayasi Ngongo, Erick Kamangu Ntambwe, Hippolyte Situakibanza Nani-Tuma, et al.
Viruses|July 29, 2023
Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIVMajdouline El Moussaoui, Salomé Desmecht, Nicolas Lambert, et al.
BMJ Open|January 26, 2022
University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocolAnne-Françoise Donneau, Michèle Guillaume, Vincent Bours, et al.
Ebiomedicine|March 3, 2019
Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathwayThijs van Montfort, Renée van der Sluis, Gilles Darcis, et al.
Viruses|June 24, 2022
Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, BelgiumMajdouline El Moussaoui, Nathalie Maes, Samuel L Hong, et al.
Frontiers in Immunology|June 17, 2022
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough InfectionsSalomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, et al.
JAMA Network Open|October 12, 2021
Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, BelgiumChristelle Meuris, Cécile Kremer, Anton Geerinck, et al.
Pageof 9